tiprankstipranks
Advertisement
Advertisement

SUPN Stock Latest News

Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
Company AnnouncementsSupernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
24d ago
SUPN
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
PremiumCompany Announcements
Supernus Pharmaceuticals Balances Record Sales With Rising Costs
25d ago
SUPN
Supernus price target raised to $65 from $60 at TD Cowen
PremiumThe Fly
Supernus price target raised to $65 from $60 at TD Cowen
1M ago
SUPN
Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
PremiumRatings
Buy Rating Backed by Reaccelerating Onapgo Demand, Sage Integration Upside, and Attractive CNS-Driven Valuation
1M ago
SUPN
Closing Bell Movers: First Solar down 12% on earnings miss
PremiumThe Fly
Closing Bell Movers: First Solar down 12% on earnings miss
1M ago
CCC
CWH
Supernus boosts executive pay with new equity incentives
PremiumCompany AnnouncementsSupernus boosts executive pay with new equity incentives
1M ago
8K
SUPN
Supernus reports Q4 EPS (7c) vs 27c last year
Premium
The Fly
Supernus reports Q4 EPS (7c) vs 27c last year
1M ago
SUPN
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
Premium
The Fly
Supernus sees FY26 revenue $840M-$870M, consensus $861.24M
1M ago
SUPN
Is SUPN a Buy, Before Earnings?
PremiumPre-Earnings
Is SUPN a Buy, Before Earnings?
1M ago
SUPN
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
PremiumRatings
Supernus: Zurzuvae Outperformance and High‑Margin Collaboration Revenue Underpin Buy Rating and $65 Price Target
2M ago
SUPN
Supernus Revises Merger Milestone Payment Obligations Agreement
PremiumCompany Announcements
Supernus Revises Merger Milestone Payment Obligations Agreement
2M ago
8K
SUPN
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
PremiumThe Fly
Jefferies sees potential tailwind forming for psychedelics from marijuana shift
3M ago
ATAI
CYBN
Supernus price target raised to $55 from $50 at Stifel
PremiumThe FlySupernus price target raised to $55 from $50 at Stifel
3M ago
SUPN
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
Premium
Ratings
Supernus Pharmaceuticals: Strategic Growth, Clinical Advances, and Strong Financial Synergies Drive Buy Rating
3M ago
SUPN
Supernus management to meet virtually with Cantor Fitzgerald
Premium
The Fly
Supernus management to meet virtually with Cantor Fitzgerald
3M ago
SUPN
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
PremiumMarket News
Bank of America Highlights Five Stocks It Says Still Offer Clear Upside in 2025
4M ago
CR
BAC
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Supernus Pharmaceuticals’ Earnings Call: Growth Amid Challenges
5M ago
SUPN
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Supernus Pharmaceuticals Reports Strong Q3 2025 Growth
5M ago
SUPN
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
PremiumRatings
Supernus Pharmaceuticals: Strong Product Performance and Strategic Management Drive Buy Rating
5M ago
SUPN
Supernus reports Q3 EPS (80c) vs. 69c last year
PremiumThe FlySupernus reports Q3 EPS (80c) vs. 69c last year
5M ago
SUPN
Supernus raises FY25 revenue view to $685M-$705M from $670M-$700M
Premium
The Fly
Supernus raises FY25 revenue view to $685M-$705M from $670M-$700M
5M ago
SUPN
Supernus Faces Supply Constraints Amid High ONAPGO Demand
Premium
Company Announcements
Supernus Faces Supply Constraints Amid High ONAPGO Demand
5M ago
8K
SUPN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >